A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

AI in Healthcare


[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

   by Andrii Buvailo    598
[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited all the way until the emergence of powerful hardware (GPUs) in the late 1990s. Other complementary technologies played an important role in the AI progress too: new data storage capabilities, cheap cloud infrastructures, advanced deep learning algorithms -- all these things became reality only in the 21st century, effectively setting AI field for exponential development trajectory and commercial practical utility. 

Today AI tech has matured to an extent it has become a strategic factor, a competitive differentiator, not only for individual companies but for the whole industries and countries. Needless to say, healthcare -- one of the major industries -- is an important end-user of AI technologies. Countries that care to adopt AI in their healthcare strategies today will have major competitive benefits for public health and safety tomorrow.

Aigenpulse introduces novel data intelligence platform to life science markets

   by Alice Chamberlain    216

Life science and data technology innovator, Aigenpulse, is introducing a new state of-the-art data intelligence platform which is designed to expedite the drug discovery and development process. The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making.

Intelligent Health AI 2020

   by BiopharmaTrend    429
Intelligent Health AI 2020

The world's leading AI in Medicine Summit 

Intelligent Health is the only large-scale, global summit series focused purely on AI in healthcare! Our CPD accredited summits bring the global AI and health community together to advance discussions on how to apply AI and drive technological collaboration in healthcare.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    293
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.

Intelligent Health Inspired

   by BiopharmaTrend    175
Intelligent Health Inspired

The world’s largest online global summit dedicated to AI in medicine where clinicians, technologists, NGO’s and c-suite executives from all over the world come together for 3 days of exclusive talks, dynamic on-demand and live content, networking and virtual meetings to create a future where AI will revolutionize health and #saveliveswithai.